Duncan Williams Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Duncan Williams Asset Management's LLY Position: Q1 2026 in Review
Duncan Williams Asset Management reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $24.3K and leaving 1,275 shares worth $1.17M. The position accounts for 0.33% of the portfolio, ranked #43.
Duncan Williams Asset Management first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.44M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Duncan Williams Asset Management held 1,275 shares of Eli Lilly worth $1.17M as of Q1 2026.
- Duncan Williams Asset Management sold 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
- Eli Lilly made up 0.33% of Duncan Williams Asset Management's portfolio in Q1 2026, its #43 holding.
- Duncan Williams Asset Management first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
- Duncan Williams Asset Management's Eli Lilly position peaked at $1.44M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Duncan Williams Asset Management's 13F filing for Q1 2026, filed 5 May 2026.